12-Dec-2025
As Oracle slides after results, see the top SA Quant-rated systems software stocks
Seeking Alpha News (Thu, 11-Dec 7:34 AM ET)
RBC Capital Sticks to Its Hold Rating for UiPath (PATH)
TipRanks (Wed, 10-Dec 6:37 AM ET)
UiPath and Talkdesk join forces to transform customer experience journeys
Globe Newswire (Tue, 9-Dec 9:00 AM ET)
UiPath (PATH) Gets a Hold from Morgan Stanley
TipRanks (Tue, 9-Dec 8:25 AM ET)
UiPath Teams Up with Veeva to Deliver Secure Agentic Testing for Life Sciences Quality Management
Market Chameleon (Thu, 4-Dec 3:35 AM ET)
Business Wire (Thu, 4-Dec 8:30 AM ET)
UiPath Reports Third Quarter Fiscal 2026 Financial Results
Business Wire (Wed, 3-Dec 4:10 PM ET)
UiPath to Participate in the Barclays 23rd Annual Global Technology Conference
Business Wire (Tue, 25-Nov 4:10 PM ET)
R Systems Earns UiPath Diamond Partner Status: What This Signals for Agentic Automation and PATH
Market Chameleon (Fri, 21-Nov 2:07 AM ET)
Business Wire (Fri, 21-Nov 5:00 AM ET)
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
Uipath Class A trades on the NYSE stock market under the symbol PATH.
As of December 12, 2025, PATH stock price declined to $17.42 with 15,793,800 million shares trading.
PATH has a beta of 1.09, meaning it tends to be more sensitive to market movements. PATH has a correlation of 0.11 to the broad based SPY ETF.
PATH has a market cap of $9.32 billion. This is considered a Mid Cap stock.
Last quarter Uipath Class A reported $411 million in Revenue and $.16 earnings per share. This beat revenue expectation by $18 million and exceeded earnings estimates by $.01.
In the last 3 years, PATH traded as high as $27.87 and as low as $9.38.
The top ETF exchange traded funds that PATH belongs to (by Net Assets): VTI, VGT, VB, BOTZ, VBK.
PATH has outperformed the market in the last year with a price return of +22.4% while the SPY ETF gained +14.0%. PATH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +52.8% and +25.7%, respectively, while the SPY returned +4.0% and -0.2%, respectively.
PATH support price is $17.36 and resistance is $18.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PATH shares will trade within this expected range on the day.